ユーザーIDをお忘れですか? or パスワードをお忘れですか?

東京ビッグサイト | 有明

2018年11月11日 (日) 午前 9:30 - 2018年11月13日 (火) 午後 5:40

〒135-0063, 東京都江東区有明3-11-1



[V5-S6] The Latest Trend of Vaccine Policy, Regulatory Regulation in Japan, the United States and Europe

Session Chair(s)

Nobuhiko  Okabe, MD

Nobuhiko Okabe, MD

Director General

Kawasaki City Institute for Public Health, Japan

Although vaccination has largely contributed to the improvement and promotion of public health, prevention of infection by vaccination will become increasingly important for the Tokyo Olympic Games to be held in 2020. In this session, we introduce the vaccination system and examination in Japan, the United States and Europe, and discuss how the differences in the system influence vaccination promotion from various viewpoints. We will also discuss experiences on benefits gained by vaccination and expectations for future vaccine administration.


Akihiko  Saitoh, MD

Immunization System in Japan - Recent Progress and Challenges -

Akihiko Saitoh, MD

Niigata University, Japan

Professor, School of Medicine Department of Pediatrics

Ercem S Atillasoy, MD

Regulatory Trends and Current Challenges for Vaccine Development in the USA

Ercem S Atillasoy, MD

Merck & Co., Inc, United States

Vice President

Shazia  Sheikh

Immunisation in Europe: an overview

Shazia Sheikh

GSK Vaccines, Belgium

Director, Communications & Government Affairs, Emerging Markets

Andrew  Otoo, PharmD, MBA

Andrew Otoo, PharmD, MBA

Pfizer Japan Inc., Japan

VP, Japan Vaccines Country Lead